Risk categories from European guidelines applied to the French Pulmonary Hypertension (PH) registry

A. Boucly (PARIS, France)

Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension
Session: Outcomes and new treatment strategies in pulmonary hypertension
Session type: Poster Discussion
Number: 3527
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Boucly (PARIS, France). Risk categories from European guidelines applied to the French Pulmonary Hypertension (PH) registry. 3527

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
Source: Eur Respir J 2015; 46: 903-975
Year: 2015



Severe Paediatric Asthma Collaborative in Europe (SPACE): protocol for a European registry
Source: Breathe, 14 (2) 93; 10.1183/20734735.002018
Year: 2018



Difficult to manage COPD Exacerbations: Risk factors (DIMECO Study). Turkish Thoracic Society COPD Assembly.
Source: Virtual Congress 2020 – Prediction and management of outcomes in obstructive diseases
Year: 2020




Assessing the financial impact of pulmonary hypertension: a survey by the UK Pulmonary Hypertension Association (PHA-UK)
Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Year: 2018

Risk assessment in Pulmonary Arterial Hypertension (PAH) based on the Simplified French Model: A single centre experience
Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond
Year: 2021


Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model
Source: Eur Respir J 2016; 48: 780-786
Year: 2016



Cross-infection risk in patients with bronchiectasis: a position statement from the European Bronchiectasis Network (EMBARC), EMBARC/ELF patient advisory group and European Reference Network (ERN-Lung) Bronchiectasis Network
Source: Eur Respir J, 51 (1) 1701937; 10.1183/13993003.01937-2017
Year: 2018



Severe Pulmonary Hypertension Management Across Europe (PHAROS): an ERS Clinical Research Collaboration
Source: Eur Respir J, 55 (5) 2001047; 10.1183/13993003.01047-2020
Year: 2020



Portopulmonary hypertension in United Kingdom: A contemporary, national, observational study
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014

2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)
Source: Guideline 2019
Year: 2019

2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)
Source: Eur Respir J, 54 (3) 1901647; 10.1183/13993003.01647-2019
Year: 2019



Screening for COPD using the Canadian Lung Association questionnaire: A practice assessment of Canadian physicians
Source: Annual Congress 2010 - Comorbidities and disease management in primary care
Year: 2010


Impact of treatment strategy in survival of patients with idiopathic pulmonary arterial hypertension. Real world evidence from Spanish National Pulmonary Hypertension Registry (REHAP)
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018

Quality of care in bronchiectasis using the European Respiratory Society Guidelines as a reference standard- data from the EMBARC registry
Source: Virtual Congress 2021 – Respiratory infections and bronchiectasis outcomes
Year: 2021



Applying the ESPEN definition of Malnutrition in patients with stable Chronic Pulmonary Obstructive Disease: associations with Mortality and Healthcare use at 2 years
Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care
Year: 2018

The OPTIEK1 study: Design and preliminary results of a Dutch national registry
Source: International Congress 2016 – Pulmonary hypertension: the clinic I
Year: 2016

Treatment of COPD Exacerbation in Switzerland - results and recommendations of the European COPD Audit
Source: International Congress 2017 – COPD management
Year: 2017

Longitudinal data-driven definition of clinical asthma phenotypes in the pediatric arm of the All Age Asthma Cohort (ALLIANCE) of the German Center for Lung Research (DZL)
Source: Virtual Congress 2020 – Hot topics in paediatric asthma
Year: 2020